Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00831766
Brief Title: Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)

First Submitted : January 28, 2009
First Submitted that Met QC Criteria : January 28, 2009
First Posted : January 29, 2009 (Estimate)

Results First Submitted : February 25, 2016
Results First Submitted that Met QC Criteria : February 25, 2016
Results First Posted : March 28, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 5, 2019
Last Update Posted : August 6, 2019